Cann Group Ltd
CAN
Company Profile
Business description
Cann Group Ltd is engaged in the cultivation of medicinal cannabis for both medicinal and research purposes under the licenses and permits issued to the company, the development and manufacture (via third-party arrangements) of finished product formulations. Geographically, the company operates in Europe and Australia. The company derives maximum revenue from Australia.
Contact
Sector
Healthcare
Stock type
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
Employees
Stocks News & Analysis
stocks
Ask the analyst: Is the market underestimating Bapcor?
This moated ASX company's shares are in a prolonged slump. I quizzed our analyst Angus Hewitt on its management, the potential impact of EVs, and more.
stocks
Is our ASX best idea still attractive after shares surge?
Shares rose over 21% following the results.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,751.60 | 4.00 | 0.05% |
| CAC 40 | 8,006.22 | 33.19 | 0.42% |
| DAX 40 | 21,911.74 | 124.74 | 0.57% |
| Dow JONES (US) | 44,470.41 | 167.01 | 0.38% |
| FTSE 100 | 8,767.80 | 67.27 | 0.77% |
| HKSE | 21,387.55 | 134.43 | -0.62% |
| NASDAQ | 19,714.27 | 190.87 | 0.98% |
| Nikkei 225 | 38,801.17 | 14.15 | 0.04% |
| NZX 50 Index | 12,917.45 | 41.10 | 0.32% |
| S&P 500 | 6,066.44 | 40.45 | 0.67% |
| S&P/ASX 200 | 8,484.00 | 1.20 | 0.01% |
| SSE Composite Index | 3,314.32 | 7.85 | -0.24% |